Cytosorbents Corp (NASDAQ:CTSO)

5.56
Delayed Data
As of 2:47pm ET
 +0.01 / +0.18%
Today’s Change
3.68
Today|||52-Week Range
13.95
-31.19%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2015

2016

2017

2018
Revenue and IncomeNet Revenues4.8M9.5M15.2M22.5M
 
 
 
 
 
Cost of Goods Sold2.1M3.8M5.3M7.1M
 
 
 
 
 
Depreciation And Amortization113.0K161.6K218.3K390.6K
 
 
 
 
 
 
Operating ExpensesGross Income2.6M5.6M9.6M15.0M
 
 
 
 
 
General Expenses11.9M17.1M19.5M30.6M
 
 
 
 
 
Research And Development3.9M4.8M4.0M7.7M
 
 
 
 
 
Total Operating Expenses14.1M21.0M25.0M38.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-9.3M-11.5M-9.8M-15.6M
 
 
 
 
 
Extraordinary Credit1.3M0.000.000.00
 
 
Extraordinary Charge0.00-175.4K0.000.00
 
 
Interest Expense On Debt0.00231.8K749.1K1.5M
 
 
 
 
Other Expenses-507.3K-358.1K1.5M-784.8K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-8.5M-12.3M-9.1M-17.8M
 
 
 
 
 
Income Taxes-324.6K-318.6K-676.7K-619.5K
 
 
 
 
 
Preferred Dividend0.000.00-335.7K0.00
 
 
Net Income-8.1M-11.9M-8.5M-17.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS24.9M25.4M27.6M30.7M
 
 
 
 
 
Shares To Calculate EPS Diluted24.9M25.4M27.6M30.7M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.33-$0.47-$0.32-$0.56
 
 
 
 
 
EPS Diluted-$0.33-$0.47-$0.32-$0.56